SEC v. Carlos Sacanell

Carlos Sacanell allegedly engaged in insider trading ahead of an announcement that CVS Health Corporation, Inc. had agreed to acquire Oak Street Health, Inc. Sacanell allegedly purchased Oak Street stock and call options based on material nonpublic information, resulting in approximately $617,000 in profits, according to the SEC.

Summary generated from official Securities and Exchange Commission press release